CellWell record HH-78252
Carotenoid Status and Psychological Impact of Presymptomatic Macular Degeneration Genetic Risk Assessment: The MAGENTA Randomized Trial
Emmanuel K Addo; Lucia Lucci; Jens Nilson; Marcela Pasaye; Chris Pappas; Emily Spoth; Lisa Ord; Amani Jridi; Ben J Brintz; Gregory S Hageman; M Elizabeth Hartnett; Paul S Bernstein
2026
In plain language
In the MAGENTA trial, 80 presymptomatic adults randomised to immediate or deferred disclosure of age-related macular degeneration genetic risk showed no change in skin, plasma or macular carotenoids at 12 months and no worsening stress.
- Evidence
- Emerging
Cite this record: https://thecellwell.org/studies/HH-78252
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.